zileuton


Also found in: Medical, Wikipedia.

zi·leu·ton

 (zī-lo͞o′tn)
n.
A drug that inhibits leukotriene formation, used to treat asthma.

[(ben)z(oth)i(ene), one of its components + leu(ko)t(riene) + -on.]
References in periodicals archive ?
Taken orally, zileuton inhibits the 5-LO enzyme, which would otherwise catalyze the formation of leukotrienes from arachidonic acid.
Different treatment modalities like cryotherapy, scarification, topical and systemic steroids, antimalarials, chlorambucil, ciclosporin, dapsone, etretinate, fumaric acid esters, isotretinoin, niacinamide, pentoxifylline, photo(chemo)therapy, potassium iodide, zileuton (a 5-lipoxygenase inhibitor), vitamin E have been tried with variable responses.
In the study, published in the March 25, 2011 issue of the American Journal of Pathology, researchers found that Zileuton reduced the build-up of amyloid plaques in the brain by more than 50 percent.
Saryan and his associates at Lahey use involves systematic pretreatment with antihistamines, leukotriene-modifying drugs such as montelukast or zileuton, and in one case, prednisone.
an associate professor of pharmacology in Temple's School of Medicine, the researchers tested the drug Zileuton, an inhibitor of 5-lipoxygenase typically used to treat asthma, in a transgenic mouse model of Alzheimer's disease.
In their current study, led by Domenico Pratico, an associate professor of pharmacology in Temple's School of Medicine, the researchers tested the drug Zileuton, an inhibitor of 5-lipoxygenase typically used to treat asthma, in a transgenic mouse model of Alzheimer's disease.
There are two other members of this class of medications, zafirlukast (Accolate) and zileuton (Zyflo).
The oral medications that patients in the study were using were the leukotriene modifiers zafirlukast (Accolate), montelukast (Singulair), and zileuton (Zyflo).
The FDA, which issued the call in mid June, said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR).
Zileuton was purchased from Sequoia Research Products Ltd.
The second classification is leukotriene-receptor inhibitors, which focus on synthesis inhibition and include zileuton (Zyflo[R]).